Patents Examined by Andrew S Rosenthal
  • Alkaline agent for lightening hair containing oxidants and special carboxylic acid esters
    Patent number: 10251826
    Abstract: The subject matter of the present disclosure includes agents for lightening keratin fibers, more particularly human hair, containing in a cosmetic carrier: (a) at least one carboxylic acid ester of the formula (I) (b) at least one peroxide compound, and (c) water, wherein the agent has a pH value in the range of from about 7.5 to about 12.5. A further subject matter of the present disclosure includes a kit-of-parts in which the aforementioned components exist packed separately in two agents (A) and (B).
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: April 9, 2019
    Assignee: Henkel AG & Co. KGaA
    Inventors: Antje Gebert-Schwarzwaelder, Helmut Giesa, Astrid Kroos
  • Gelatin/pectin particles
    Patent number: 10238603
    Abstract: Disclosed are particles comprising pectin and gelatin. The particles may be useful for preparing any of a variety products such as, for example, soft pharmaceutical capsules, hard pharmaceutical capsules, and foodstuffs. Also disclosed are methods for preparing the particles, the method comprising: (a) dissolving pectin in an aqueous solution to produce an aqueous solution of dissolved pectin; (b) mixing the aqueous solution of dissolved pectin with liquid gelatin to produce a gelatin/pectin mixture; (c) drying the gelatin/pectin mixture; and (d) milling the gelatin/pectin mixture to produce the plurality of particles.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: March 26, 2019
    Assignee: GELITA AG
    Inventors: John M. Dolphin, Michelle A. Montgomery
  • Compositions for altering the color of hair
    Patent number: 10231915
    Abstract: The disclosure relates to systems and compositions comprising the systems for use in chemical treatment of keratinous substrates, such as the hair. The systems and compositions comprising the systems comprise at least one active agent and at least one acid. Methods of treating keratinous substrates with the systems and compositions comprising the systems are also disclosed.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: March 19, 2019
    Assignee: L'OREAL
    Inventors: Kimberly Dreher, Gérard Provot, Dariusz Danielski, Fabien Boulineau, Caroline Rahmouna Francoise Goget, Anthony Potin, Allison Chin, Michael DeGeorge, Mara Applebaum, Mary Abraam Soliman, Ashley Ann Figatner, Megan Pauker, Emmanuel Appiah-Amponsah
  • Bola-amphiphilic compounds and their uses for biomedical applications
    Patent number: 10227372
    Abstract: The invention relates to bola-amphiphilic compounds and their uses for biomedical application. The invention particularly relates to the use of bola-amphiphilic compounds for providing low molecular weight gels (LMWG), useful, in particular, as culture media for animal or human cells, or as biocompatible material for biomedical applications.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: March 12, 2019
    Assignees: UNIVERSITE DE BORDEAUX, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Philippe Barthelemy, Michael Ramin, Laurent Latxague, Ananda Appavoo, Olivier Chassande, Camille Ehret
  • Nanotubes and compositions thereof
    Patent number: 10201634
    Abstract: The present invention is directed to implants and the modification of the surface of implants using amino acid or polypeptide functionalized rosette nanotubes.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: February 12, 2019
    Assignees: Brown University, National Research Council of Canada, The Governors of the University of Alberta
    Inventors: Thomas J. Webster, Hicham Fenniri, Usha Devi Hemraz
  • Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas
    Patent number: 10201566
    Abstract: The invention relates to compositions containing selenite-containing compounds and pharmaceutically acceptable acids, selected from citric acid, acetic acid, malic acid, carbonic acid, sulphuric acid, nitric acid, hydrochloric acid, fruit acids or mixtures thereof, for use for treating cervical inflammations, dysplasia and/or carcinomas. The invention further relates to methods of using such compositions.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: February 12, 2019
    Assignee: SELO MEDICAL GMBH
    Inventor: Norbert Fuchs
  • Hydrates of dolutegravir sodium
    Patent number: 10189860
    Abstract: The invention relates to novel hydrates of dolutegravir sodium and to processes for their preparation. Furthermore, the invention relates to a novel crystalline form of dolutegravir sodium, which is a useful intermediate for the preparation of one of the novel hydrates. In addition, the invention relates to the use of the novel hydrates for the production of pharmaceutical compositions. Finally, the invention relates to pharmaceutical compositions comprising an effective amount of the novel hydrates, to oral dosage forms comprising said pharmaceutical compositions, to a process for preparing said oral dosage forms, and to the use of said pharmaceutical compositions or dosage forms in the treatment of retroviral infections such as HIV-1 infections.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: January 29, 2019
    Inventors: Andreas Hotter, Andrea Thaler, Andrija Lebar, Biljana Jankovic, Klemen Naversnik, Uros Klancar, Zrinka Abramovic
  • Pharmaceutical compositions of dimethyl fumarate
    Patent number: 10179118
    Abstract: Pharmaceutical compositions and dosage forms of dimethyl fumarate containing low levels of certain impurities are disclosed.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: January 15, 2019
    Assignee: ARBOR PHARMACEUTICALS, LLC
    Inventors: Sami Karaborni, Wei Chen, Suresh Kumar Manthati
  • Physiological cooling compounds
    Patent number: 10173966
    Abstract: Physiological cooling compounds of the structure: where R1 is p-menthyl or 2,3,4-trimethylpent-3-yl group and R2-R8 are hydrogen or alkyl groups. The combination of R2-R8 is such that the N-alkyl group is a branched C5 alkyl or branched or linear C6-C8 alkyl group. The new carboxamides are valuable sensory ingredients which provide long-lasting cooling sensation and freshness in personal care, oral care, cosmetic products, pharmaceutical preparations, confectionary, food and beverages.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: January 8, 2019
    Assignee: SYMRISE, INC.
    Inventors: Gennadiy G. Kolomeyer, David J. Sitko, Joe W. Snow
  • Afobazole nanoparticles formulation for enhanced therapeutics
    Patent number: 10172867
    Abstract: A novel nanoparticle drug composition and method of use thereof is presented herein. The nanoparticle drug composition is comprised of at least one nanoparticle carrier, formed from the conjugation of PLGA and PEG, which encapsulates a drug such as afobazole and its derivatives, in a pharmaceutically acceptable carrier. The nanoparticle drug composition may be used to treat various diseases of the central nervous system involving excessive neuronal activity and inflammation such as stroke, Alzheimer's disease and anxiety.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: January 8, 2019
    Assignee: University of South Florida
    Inventors: Javier Cuevas, Christopher Katnik, Vijaykumar B. Sutariya
  • Solvent system for use with spot-on pesticide compositions
    Patent number: 10172359
    Abstract: A solvent system, and spot-on pesticide composition comprising the solvent system and a combination of active pesticidal compounds for the treatment or prevention of insect, parasite, or tick infestations in animals, specifically mammals, including dogs and cats. The solvent system is capable of allowing high concentrations of the active pesticides, while maintaining shelf life and resistance to repeated cycles of freezing and thawing normally encountered during shipping, for example.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: January 8, 2019
    Assignee: Sergeant's Pet Care Products, Inc.
    Inventors: Matt Latner, James McElroy, Roslyn White, Mark Levin
  • Lipids and lipid nanoparticle formulations for delivery of nucleic acids
    Patent number: 10166298
    Abstract: Compounds are provided having the following structure: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, L1, L2, G1, G2 and G3 are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: January 1, 2019
    Assignee: Acuitas Therapeutics, Inc.
    Inventors: Steven M. Ansell, Xinyao Du
  • Agent for inhibiting odor of pyrazine derivatives
    Patent number: 10159655
    Abstract: Provided is an agent for reducing odors of pyrazine derivatives based on an olfactory receptor antagonism. The agent for reducing odors of pyrazine derivatives includes at least one antagonist of olfactory receptor OR5K1 as an active ingredient.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: December 25, 2018
    Assignee: KAO Corporation
    Inventors: Aya Kato, Naoko Saito, Michiaki Inoue, Kayoko Nomizu
  • Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
    Patent number: 10160705
    Abstract: Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: December 25, 2018
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Billy W. Day, Neil Hukriede
  • Compositions for the treatment of sweating and methods for making same
    Patent number: 10149805
    Abstract: The invention describes novel compositions and methods utilized for treating disorders and/or conditions associated with the epidermal and/or dermal level of the skin. Such disorders include hyperhidrosis, bromhidrosis, and chromhidrosis, One representative composition of the invention comprises; water, alcohol, aluminum sesquichlorohydrate, hydroxypropyl methyl cellulose, polysorbate 20, isopropyl myristate, eucalyptus oil, silicone oil, alkyl benzoate, glycerine, talc, a hydrophillic silica, a hydrophobic silica, phenoxyethanol and ethylhexyl glycerine.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: December 11, 2018
    Assignee: CLUTCH, INC.
    Inventors: David Bradley Spratte, Jr., Christopher Jenks, Kasper Kubica, Mary Claire Brehm, Shari Deanna Angelina Fonte Clemente
  • Cosmetic compositions containing acrylic thickener
    Patent number: 10143645
    Abstract: The invention relates to a composition, especially a cosmetic composition, comprising at least one acrylic thickener and at least one oil, as well as to methods of using such compositions.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: December 4, 2018
    Assignee: L'OREAL
    Inventors: Chunhua Li, Hy Si Bui, Dhaval Patel, Mohamed Kanji, Geoffrey White
  • Nanoparticulate composition containing antibiotics for intramammary administration in animals
    Patent number: 10098840
    Abstract: The present invention relates to the development of two types of polymer nanocapsules to encapsulate cloxacillin benzathine, an antimicrobial drug. More specifically, this invention relates to a new form of treatment for mastitis in dairy cattle. Two nanocapsule formulations have been developed and can be used to encapsulate various drugs, besides cloxacillin benzathine, providing a new therapy for mastitis in cows, avoiding the inconvenience of the use of high doses of drugs used in conventional formulations, thus contributing to an improvement in milk quality.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: October 16, 2018
    Assignees: UNIVERSIDADE FEDERAL DE OURO PRETO, EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA-EMBRAPA, FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE MINAS GERAIS-FAPEMIG
    Inventors: Vanessa Carla Furtado Mosqueira, Raquel Silva Araújo, Humberto de Mello Brandão
  • Treatment of proliferative disorders with a chemiluminescent agent
    Patent number: 10092565
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminescent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: October 9, 2018
    Assignees: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer
  • Solid compositions for pharmaceutical use
    Patent number: 10092660
    Abstract: The invention relates to solid compositions that may be suitable for administering a therapeutic agent to a subject. The invention also relates to methods of making such solid compositions. The invention further relates to methods of treating a disease, condition, or disorder by administering to a subject such solid compositions.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: October 9, 2018
    Assignee: STC.UNM
    Inventors: Hugh Smyth, Ibrahim M. El-Sherbiny
  • N-halamine melamine derivatives as novel decontamination and biocidal agents
    Patent number: 10072106
    Abstract: The present disclosure relates to the field of decontamination and biocidal agents. More specifically, the invention relates to novel N-halamine melamine derivatives, compositions comprising them, processes for their production, and methods using the same.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: September 11, 2018
    Assignee: State of Israel, Prime Minister's Office, Israel Insitute For Biological Research
    Inventors: Dana M. Mizrahi, Ishay Columbus